AI-designed drug reduces fentanyl consumption in animal models by targeting serotonin receptors (opens in new tab)

An experimental drug developed using artificial intelligence shows promise in treating opioid use disorder. The medication significantly lowered fentanyl intake in rodents by targeting serotonin receptors, promoting healthy brain adaptation without relying on traditional opioid-based treatments.